News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances (World)
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ) 10/24/2014
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK) 10/24/2014
Covidien (COV) Joins Forces With American Lung Association To Help Women Understand Their Increased Risk Of Lung Cancer 10/23/2014
MorphoSys AG To Receive Milestone Payment For Guselkumab Phase 3 Program 10/23/2014
Neovacs SA And Kepler Cheuvreux Sign A Financing Project 10/23/2014
Inocucor Technologies And McGill University To Collaborate On Bio-Stimulants For Large-Scale Agriculture 10/23/2014
Lucideon (Formerly Known As CERAM) To Jointly Run Biodensol Project 10/23/2014
R-Tech Ueno: Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda (TKPYY) Enter Into Global Licensing Agreement For AMITIZA® (Lubiprostone) 10/23/2014
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses 10/22/2014
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million 10/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza® 10/22/2014
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin) 10/22/2014
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist 10/22/2014
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company 10/22/2014
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/21/2014
Sysfera And Kitware Partner To Integrate HPC Technologies For Improved Scientific Data Analysis 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Addex Therapeutics (ADXN.SW) And The Charcot-Marie-Tooth Association Enter Collaboration To Advance ADX71441 In Charcot-Marie-Tooth 1A Disorder 10/21/2014
Calixar And Aston University Together In Collaborative Research To Tackle Multidrug Resistance Targets 10/20/2014
Sirona Biochem Announces Research Collaboration With Aegilops Applications 10/20/2014
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014
Clean TeQ Holdings Limited (ASX:CLQ) And SIDRI Sign Heads Of Agreement 10/20/2014
Sihuan Pharmaceutical Announces Second Anti-Virus Partnership With AMMS 10/17/2014
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014
AstraZeneca PLC (AZN) Strengthens Partnership With The University of Cambridge 10/16/2014
Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™ 10/16/2014
Cardiorentis AG And Roche (RHHBY) Announce Collaboration To Establish Therapeutic Impact Of Ularitide 10/16/2014
Auspherix And Domainex Announce Collaboration To Develop New Drugs To Treat Antibiotic-Resistant Bacterial Infections 10/15/2014
Deinove Teams Up With MBI, Pioneer Of Afex Technology, To Evaluate Its Process On Industrial Biomass 10/15/2014
Embattled Wilex AG (WL6.DE) Sells Unnamed Tumor Drug To Roche (RHHBY) For $65.8M 10/14/2014
Advanced Biological Laboratories SA (ABL), University of Hong Kong, And The Hong Kong Polytechnic University Decide To Join Forces To Develop A Deep-Sequencing Tuberculosis Solution 10/14/2014
Imaxio Signs An Option For A License Agreement With The German Cancer Research Center (DKFZ) 10/14/2014
BioSilta And Sigma-Aldrich Corporation (SIAL) Sign Global Distribution Agreement 10/14/2014
New Oncology And Gustave Roussy Announce Collaboration On Genetic Testing 10/14/2014
Sihuan Pharma Buys Rights To Ebola Drug From China's AMMS 10/13/2014
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014
Hikma Pharmaceuticals Enters Partnership With Eisai Company, Ltd. (ESALY.PK) For Distribution Of First-In-Class Epilepsy Treatment Fycompa® In Middle East 10/13/2014
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers 10/13/2014
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014
Pharming Group (PHGUF.PK) And Swedish Orphan Biovitrum Amend And Extend Ruconest Distribution Agreement 10/13/2014
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium 10/13/2014
MRC Technology And Proximagen Group plc. Collaborate To Develop Novel Therapeutics For Inflammatory And Autoimmune Disease 10/13/2014
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014
Oxford BioMedica PLC (OXB.L) Inks Transformational $90 Million Deal With Novartis AG (NVS) 10/10/2014
We've Secured Third Biosimilar License: Stada CEO 10/10/2014
A*STAR’s Simtech Joins Hands With 8 Companies To Overcome Counting, Tracking And Supply Chain Woes 10/9/2014
ContraFect Corporation (CFRXU) And National Institute For Viral Disease Control And Prevention, China CDC Sign Agreement To Collaborate On Universal Influenza Treatment 10/9/2014
Tekmira (TKMR) Working Hand In Hand With WHO On Ebola Drug, Says CEO 10/8/2014
Cardio3 BioSciences Awarded Preferred Access Rights To Mayo Clinic Center For Regenerative Medicine Portfolio 10/8/2014
Dilafor Signs Supply And Partnership Agreement With OPOCRIN S.p.A 10/8/2014
Ubiquigent And University of Dundee Announce Collaboration To Develop Novel Ubiquitin System Targeted Compound Libraries 10/8/2014
BASF And Colorcon, Inc. Cooperate On Kollicoat® IR For Ready-To-Use Pharmaceutical Coating Solutions 10/8/2014
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014
Collaboration With Dr. Stephen Waxman Of Yale University To Evaluate Pharmacology Of Nav1.7 Mutations In Chronic Pain Disorders 10/6/2014
Horizon Discovery Group Signs Co-Exclusive Commercial Agreement With Haplogen Genomics 10/6/2014
ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development 10/6/2014
Lockheed Martin Corporation And Yissum Ltd. Sign Long Term Research Collaboration Agreement 10/6/2014
India Brand Equity Foundation (IBEF), Release: Government Of India And Pharma Industry Jointly Form The India – Responsible Healthcare Trust 10/6/2014
Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact 10/6/2014
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014
The Reason Why Takeda Pharmaceutical Co. Ltd. (TKPYY) May Pay MacroGenics, Inc. (MGNX) Up To $1.6 Billion For Four Molecules That Don't Yet Exist 10/6/2014
Ariad Pharmaceuticals, Inc. (ARIA), Bellicum Pharmaceuticals, Inc. Revise Pact; Ariad Will Receive $50 Million In Three Installments 10/6/2014
NetScientific’s Subsidiary, Glycotest Begins A New Research Collaboration With Oncimmune LLC 10/3/2014
A*STAR And Japan Science And Technology Agency Renews Research Cooperation 10/3/2014
D&A Pharma Signs Licensing And Distribution Agreement With Grupo JUSTE For ALCOVER® In Spain And Central America 10/3/2014
Oxford BioTherapeutics And Berlin-Chemie/Menarini Group Progress Antibody-Drug Conjugate As Second Clinical Development Candidate In $1 Billion Oncology Investment Alliance 10/2/2014
VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center 10/2/2014
Cambridge Research Biochemicals Signs Licensing Deal With The Scripps Research Institute 10/2/2014
MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draw Up $1.6B DART Pact 10/1/2014
Bitplane Brings Voloom To The Wider Life Sciences Market 10/1/2014
MannKind Corporation (MNKD) Pockets $150 Million Upfront Payment From Sanofi (France) (SAN.PA) 9/30/2014
Pfizer (PFE), Kyowa Hakko Kirin Team Up On Immuno-Oncology Combination Study 9/30/2014
Evotec AG (EVTG.F) Receives Milestone As Part Of Its Multi-Target Alliance With Bayer HealthCare (BAY) 9/30/2014
Lead Discovery Center Enters First Collaboration With The Helmholtz Association 9/30/2014
Celerion Expands Ophthalmological Capabilities To Patient Populations In Collaboration With Queen’s University, Belfast. 9/30/2014
DanDrit Biotech A/S Signs Agreement To Commence Clinical Trials Of MelcancerVac® 9/30/2014
Horus Pharma And NovaMedica Sign Agreement To Market A Portfolio Of Eye Care Products In Russia 9/30/2014
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014
Kamada Ltd. (KMDA) Extends Glassia Agreement With Baxter International, Inc. (BAX) 9/29/2014
Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA) 9/29/2014
PharmaEngine, Inc. And Merrimack Amend MM-398 License Agreement 9/26/2014
Sumitomo Dainippon Pharma, SanBio, Inc. Strike $199 Million Stroke Deal 9/26/2014
Sagent Pharmaceuticals, Inc.-Hengrui Partnership Launches Second Cancer Drug In U.S. 9/26/2014
Bay Area's Pharmacyclics, Inc. (PCYC) Stock Slumps After Ending Servier Collaboration 9/26/2014
BioMotiv Attracts $25 Million Investment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 9/26/2014
MetaSysX, Potsdam Is Pleased To Announce The Closure Of A Service Agreement With Bayer CropScience AG 9/26/2014
Gilead Sciences, Inc. (GILD) Release: The Medicines Patent Pool Adds New Sub-Licensing Agreements To Improve Access To Novel Arvs In Developing Countries 9/25/2014
PHT Corporation Logpad® System Selected By Agile Therapeutics, Inc. For Use In Its Phase 3 Trial Of Twirla® Investigational Contraceptive Patch 9/24/2014
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014
SCHOTT Corporation And Algatechnologies Join R&D Forces 9/22/2014
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs 9/22/2014
Abcam plc (ABC.L) Licenses Novel Ceefourin Inhibitors Of Multidrug Resistance Protein 4 From Australia’s Children’s Cancer Institute 9/22/2014
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/19/2014
BioTie Therapies Corp.: Selincro Enters The Market In France 9/19/2014
Swedish Orphan Biovitrum Expands Haemophilia Development Portfolio - Elects To Include Potentially Longer-Acting Haemophilia A Candidate In Collaboration Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB) 9/19/2014
Merck KGaA (MKGAF.PK) Wants Bids For Cancer Therapy Partners 9/18/2014
Galen Signs Exclusive Deal In Europe 9/18/2014
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014
NuView Life Sciences Inc. Enters Global Licensing Agreement With Otsuka Pharmaceutical Co., Ltd. 9/17/2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C 9/17/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA) 9/17/2014
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug 9/17/2014
South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK) 9/17/2014
Eisai Company, Ltd. (ESALY.PK) Enters Two Joint Research Agreements To Develop New Antimalarial Medicines 9/16/2014
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/16/2014
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease 9/16/2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014
Cellprothera And BioCardia Partner On Phase 2 EXCELLENT Trial 9/15/2014
Evotec AG (EVTG.F) And The Jain Foundation Expand Collaboration: Start Of Multiple Drug Screening Programmes 9/15/2014
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014
BGI And The Vancouver Prostate Centre Announce Partnership To Create Joint Research Laboratory For Advancement Of Translational Cancer Research 9/12/2014
Evotec AG (EVTG.F) And CHDI, Inc. Foundation Extend Ongoing Collaboration To Fight Huntington's Disease 9/11/2014
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base 9/11/2014
Eisai Company, Ltd. (ESALY.PK) And Kyorin Pharmaceutical Co., Ltd. Enter Into Agreement Concerning Compound Library Use For The Development Of New Antibacterial Agents 9/11/2014
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014
Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal 9/10/2014
Inocucor Technologies Signs First Commercial Strategic Partnership With Axter Agroscience 9/10/2014
Medidata Solutions, Inc. And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials 9/10/2014
NeuroVive Pharmaceutical AB, Oncore Sign $150 Million Hepatitis B Pact 9/9/2014
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014
Zhejiang Huahai And Tianjin Pharma To Form U.S.-Aimed Partnership 9/8/2014
University of Toronto Announces Strategic Collaboration With Janssen Inc. And Johnson & Johnson Innovation (JNJ) 9/8/2014
Solentim Ltd Embraces CRISPR And Other Rapid Gene-Editing Technologies With Horizon Discovery Ltd. 9/8/2014
Lee's Pharm In-licenses Second Product From Italy's Abiogen Pharma 9/8/2014
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014
Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK 9/5/2014
Earlier Tumour Diagnosis With Advanced Ultrasound Technology From Oxford University 9/5/2014
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC (AZN); Financial Terms Have Not Been Disclosed 9/4/2014
Masters Speciality Pharma Enters Agreement With ApoPharma 9/4/2014
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The NIH 9/4/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014
Pfizer Inc. (PFE), Roche (RHHBY) Join Consortium In Effort To Up Success Of Late-Phase Clinical Work 8/6/2014
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014
Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs 8/6/2014
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014
Yabao Pharmaceuticals And Changzhou Le Sun Pharmaceuticals Ltd. Enter An Innovative Partnership To Develop Early-Stage Oncology Compound 8/6/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Cesca Therapeutics And Fortis Healthcare Announce Master Collaboration Agreement 8/5/2014
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014
BioGasol Establishes Licensed Carbofrac® Reactor Manufacture By Sweetwater Energy 8/4/2014
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration 7/30/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests 7/29/2014
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014
SDK And BIA Separations Expanding Their Co-operation 7/29/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London 7/28/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy 7/22/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences To Speed The Availability Of Generic HIV Medicines To Developing Countries 7/17/2014



//-->